Michelle Robertson - Mar 3, 2022 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
EVP, CHIEF FINANCIAL OFFICER
Signature
/s/ Michelle Robertson
Stock symbol
EDIT
Transactions as of
Mar 3, 2022
Transactions value $
-$13,290
Form type
4
Date filed
3/7/2022, 03:15 PM
Previous filing
Feb 11, 2022
Next filing
Dec 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDIT Common Stock Sale -$13.3K -767 -0.9% $17.33 84.2K Mar 3, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on December 30, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2022. The sale does not represent a discretionary trade by the Reporting Person.